Disposition of 1267 shares by Bohen Sean of Olema Pharmaceuticals at 9. subject to Rule 16b-3

OLMA Stock  USD 6.10  0.25  4.27%   
About 59% of all Olema Pharmaceuticals' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Olema Pharmaceuticals suggests that some traders are interested. The current market sentiment, together with Olema Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Olema Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Olema Pharmaceuticals Director, Officer: President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 1267 common stock at 9.39 of Olema Pharmaceuticals by Bohen Sean on 11th of December 2024. This event was filed by Olema Pharmaceuticals with SEC on 2024-12-11. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Olema Pharmaceuticals' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Olema Pharmaceuticals' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Olema Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Olema Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Olema Pharmaceuticals Fundamental Analysis

We analyze Olema Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Olema Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Olema Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Shares Shorted

Number Of Shares Shorted Comparative Analysis

Olema Pharmaceuticals is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Olema Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Olema Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Olema Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Olema Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Olema Pharmaceuticals Related Equities

GLUEMonte Rosa   6.45   
0%
57.0%
CGEMCullinan Oncology   5.94   
0%
52.0%
DSGNDesign Therapeutics   4.34   
0%
38.0%
MLYSMineralys Therapeutics,   4.31   
0%
38.0%
FENCFennec Pharmaceuticals   3.18   
0%
28.0%
SANASana Biotechnology   3.12   
0%
27.0%
PHVSPharvaris   2.95   
0%
26.0%
OBIOOrchestra BioMed   2.50   
0%
22.0%
ZNTLZentalis Pharmaceuticals   2.39   
0%
21.0%
IRONDisc Medicine   1.57   
0%
13.0%
LRMRLarimar Therapeutics   0.75   
0%
6.0%
NVCTNuvectis Pharma   0.21   
1.0%
0%
ANTXAN2 Therapeutics   0.79   
7.0%
0%
MOLNMolecular Partners   1.51   
13.0%
0%
ERASErasca   1.61   
14.0%
0%
CNTACentessa Pharmaceuticals   2.22   
19.0%
0%
PEPGPepGen   11.25   
100.0%
0%

Complementary Tools for Olema Stock analysis

When running Olema Pharmaceuticals' price analysis, check to measure Olema Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Olema Pharmaceuticals is operating at the current time. Most of Olema Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Olema Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Olema Pharmaceuticals' price. Additionally, you may evaluate how the addition of Olema Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios